http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4103026-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_449ab6bf0f0920d7db50d519ecc8d0f7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
filingDate 1977-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1978-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_724015fa66a0cd1c41e8fa8dfb8b81fe
publicationDate 1978-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4103026-A
titleOfInvention Treatment of peripheral vascular disease by non-intraarterial administration of prostaglandin E1
abstract A method of treating peripheral vascular disease in humans by non-arterial, systemic administration of prostaglandin E1, its pharmacologically acceptable salts, lower alkyl esters or amide.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4254145-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5807895-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5380760-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4820732-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962393-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0159784-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4955878-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5480648-A
priorityDate 1976-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127511947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129408444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395971

Total number of triples: 25.